| scholarly article | Q13442814 |
| P50 | author | George Mazariegos | Q42906177 |
| P2093 | author name string | Yue Zhu | |
| Bruce P Amiot | |||
| Michael E Devera | |||
| John F Patzer | |||
| David J Kramer | |||
| Roberto C Lopez | |||
| Mauricio Giraldo | |||
| Tracy A Grogan | |||
| Melissa L Fulmer | |||
| P2860 | cites work | Fulminant hepatic failure | Q33540212 |
| Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure | Q34408649 | ||
| Long-term liver cell cultures in bioreactors and possible application for liver support | Q41594567 | ||
| Safety observations in phase I clinical evaluation of the Excorp Medical Bioartificial Liver Support System after the first four patients | Q43749895 | ||
| Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial | Q44413698 | ||
| Novel bioartificial liver support system: preclinical evaluation. | Q51449625 | ||
| Experimental evaluation of a hybrid liver support system | Q73279580 | ||
| Plasma versus whole blood perfusion in a bioartificial liver assist device | Q74274249 | ||
| Treatment of severe liver failure with a bioartificial liver | Q74621723 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 260-266 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | First clinical use of a novel bioartificial liver support system (BLSS). | |
| P478 | volume | 2 |
| Q35913437 | A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems |
| Q30234560 | Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference |
| Q26800575 | Advanced therapeutic strategies for HBV-related acute-on-chronic liver failure |
| Q36802514 | Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients |
| Q45171054 | BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen |
| Q39348395 | Bifunctional polyethersulfone hollow fiber with a porous, single-layer skin for use as a bioartificial liver bioreactor. |
| Q92323574 | Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature |
| Q37202810 | Bioartificial liver systems: why, what, whither? |
| Q36530003 | Bioreactors for extracorporeal liver support |
| Q27001113 | Cell sources, liver support systems and liver tissue engineering: alternatives to liver transplantation |
| Q53155879 | Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues. |
| Q39217787 | Clinical translation of bioartificial liver support systems with human pluripotent stem cell-derived hepatic cells |
| Q51423873 | Development and perspectives of perfusion treatment for liver failure. |
| Q51147609 | Effect of membranes on oxygen transfer rate and consumption within a newly developed three-compartment bioartificial liver device: Advanced experimental and theoretical studies. |
| Q90173821 | End-stage liver failure: filling the treatment gap at the intensive care unit |
| Q38055288 | Extracorporeal liver support |
| Q38740963 | Extracorporeal support for patients with acute and acute on chronic liver failure |
| Q35781251 | Hepatic tissue engineering |
| Q35578597 | Hepatocyte hollow-fibre bioreactors: design, set-up, validation and applications |
| Q36031618 | History of xenotransplantation |
| Q44844495 | Intracranial pressure observations in a canine model of acute liver failure supported by a bioartificial liver support system |
| Q38016613 | Key challenges to the development of extracorporeal bioartificial liver support systems |
| Q38089346 | Liver tissue engineering and cell sources: issues and challenges |
| Q44789617 | Pharmacokinetic considerations in development of a bioartificial liver |
| Q44419245 | Polyomavirus reactivation in native kidneys of pancreas alone allograft recipients |
| Q34190490 | Position Paper of the Ethics Committee of the International Xenotransplantation Association |
| Q44135487 | Preclinical evaluation of the Excorp Medical, Inc, Bioartificial Liver Support System |
| Q33237089 | Similarities in the immunoglobulin response and VH gene usage in rhesus monkeys and humans exposed to porcine hepatocytes |
| Q35706287 | Systematic review: extracorporeal bio-artificial liver-support system for liver failure |
| Q36304257 | Technology insight: liver support systems |
| Q35106639 | The Year in Review – ATC 2002 |
| Q46170293 | Use of a pediatric end-stage liver disease score for deceased donor allocation: the United States experience |
| Q93140593 | When to use renal replacement therapy and bioartificial support for renal failure in patients with cirrhosis |
| Q73925431 | [Acute liver failure] |
| Q75198763 | [Liver replacement therapy. Reliable indications in acute liver failure] |
Search more.